SCHEMBL23949334

SCHEMBL23949334

COCc1ccc(O)nc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
HTT P42858 2/20 0.39
NPC1 O15118 1/20 0.39
ALOX12 P18054 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39
TUBB2A Q13885 1/20 0.39
TUBB8 Q3ZCM7 1/20 0.39
TUBA3E Q6PEY2 1/20 0.39
TUBA1A Q71U36 1/20 0.39
TUBA1C Q9BQE3 1/20 0.39
TUBB6 Q9BUF5 1/20 0.39
TUBB2B Q9BVA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15595871 0.80 TUBB4A (0.51) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL8325450 0.78 TUBB4A (0.40) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL25442970 0.77 TUBB4A (0.42) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL20539555 0.75 PDXK (0.39) KDM4EHTTNPC1RAB9AALDH1A1
SCHEMBL15595869 0.72 GSK3B (0.36) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL15595870 0.72 TAAR1 (0.36) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL15595885 0.71 TUBB4A (0.33) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL28434066 0.69 TUBB4A (0.40) KDM4EHTTNPC1ALOX12RAB9A
SCHEMBL3208786 0.68 L3MBTL1 (0.43) KDM4EHTTNPC1RAB9ANPSR1
SCHEMBL13318422 0.68 HSD17B10 (0.48) HTTALDH1A1PRKCEMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210323922-A1 PD-1/PD-L1 INHIBITORS GILEAD SCIENCES, INC. (US) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323922-A1 PD-1/PD-L1 INHIBITORS CD274, PDCD1, PDCD1LG2 KDM4E 1276/4885HTT 4182/4885NPC1 1887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.